Highlights
A mitochondria-targeted fluorescent probe for cisplatin
June 09, 2021NUS chemists have developed a mitochondria-targeted fluorescent probe for real-time imaging of clinically-important anticancer drug cisplatin in live cancer cell…
Read More
Treating aggressive breast cancer with an anti-diabetic drug
April 21, 2021NUS researchers developed an approach to target highly resistant triple-negative breast cancers (TNBCs) by interfering with their energy production using…
Read More
Antibacterial prodrug by targeting intracellular metabolite
October 09, 2020NUS researchers have developed an approach to selectively target pathogenic bacteria by harnessing an intracellular metabolite known as formate, abundant…
Read More
A ratiometric fluorescent probe for cisplatin
February 19, 2019NUS chemists have developed a novel ratiometric fluorescent probe for studying cellular activity of the clinically important anticancer drug cisplatin…
Read More
Methodology to identify drug candidates for multidrug resistant cancers
June 28, 201728 Jun 2017. NUS chemists have developed a simple and robust bio-screening method to identify anticancer drug candidates to overcome multidrug…
Read More
Uncovering secrets behind FTO specificity
January 03, 20173 Jan 2017. NUS scientists have discovered how FTO (or fat mass and obesity-associated protein), a protein strongly associated with…
Read More